Detection of AMPAR antibodies in blood and cerebrospinal fluid is a clear diagnostic marker for anti-AMPAR encephalitis, and antibodies targeting GluA1 and GluA2 subunits can be detected simultaneously or separately, with GluA2-specific antibodies being more common. The gene discussed is GRIA2; the disease is encephalitis.